JPM 2025 Offered a Glimmer of Hope, Offered in Pink
This year's JPM Healthcare conference delivered a hopeful outlook for the future of biopharma for 2025.
A New Sheriff in Town—What Can the Life Sciences Expect from a Biden White House?
We’ve all had enough of talk of the past! Let’s look at what the future might hold for the life science industry – and its marketers – under the policy changes promised by
Looking Back at the Trump Administration’s Impact on the Life Science Industry
Four years ago, Erik Clausen, CG Life Managing Partner, predicted the Trump Administration's impact on the Life Sciences and it's marketers (like us). Find if he was right in this